TY  - CHAP
M1  - Book, Section
TI  - Management of Hemoptysis in Lung Cancer
A1  - McNamee, Ciaran J.
A1  - LeSiege, Chris
A1  - Oh, Daniel
A2  - Sugarbaker, David J.
A2  - Bueno, Raphael
A2  - Burt, Bryan M.
A2  - Groth, Shawn S.
A2  - Loor, Gabriel
A2  - Wolf, Andrea S.
A2  - Williams, Marcia
A2  - Adams, Ann
Y1  - 2020
N1  - 
T2  - Sugarbaker’s Adult Chest Surgery, 3e
AB  - Hemoptysis  can  occur  at  any  stage  of  lung  cancer,  from  diagnosis  to  the  terminal  care  of  lung  cancer  patients.  The  clinical  management  of  malignancy-associated  hemoptysis  may  additionally  be  aggravated  by  systemic  anticoagulation  therapies  or  other  concomitant  pulmonary  disease  states,  such  as  inflammatory/infectious  lung  disease  or  pulmonary  vascular  abnormalities.1  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accesssurgery.mhmedical.com/content.aspx?aid=1170411234
ER  -